These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15629590

  • 1. Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI.
    McLaughlin PW, Narayana V, Meirovitz A, Troyer S, Roberson PL, Gonda R, Sandler H, Marsh L, Lawrence T, Kessler M.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):20-31. PubMed ID: 15629590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency-sparing radiotherapy?
    Roach M.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):1-2. PubMed ID: 15629584
    [No Abstract] [Full Text] [Related]

  • 5. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.
    Ciabatti S, Ntreta M, Buwenge M, Gaudiano C, Sessagesimi E, Romani F, Angelini AL, Cammelli S, Macchia G, Deodato F, Zamagni A, Golfieri R, Morganti AG, Cilla S.
    Med Dosim; 2005 Jan 01; 44(4):356-364. PubMed ID: 30955990
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional anatomy of the prostate: implications for treatment planning.
    McLaughlin PW, Troyer S, Berri S, Narayana V, Meirowitz A, Roberson PL, Montie J.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):479-91. PubMed ID: 16168840
    [Abstract] [Full Text] [Related]

  • 9. Role of IMRT in reducing penile doses in dose escalation for prostate cancer.
    Sethi A, Mohideen N, Leybovich L, Mulhall J.
    Int J Radiat Oncol Biol Phys; 2003 Mar 15; 55(4):970-8. PubMed ID: 12605975
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Utility of Penile Bulb Contouring to Localise the Prostate Apex as Compared to Urethrography.
    Lock MI, Heinrichs A, Bhattacharya G, Cusano E, Ash R, D'Souza D, Rodrigues G, Dinniwell R, Venkatesan V, Bauman G, Wong E.
    J Med Imaging Radiat Sci; 2018 Mar 15; 49(1):76-83. PubMed ID: 30479293
    [Abstract] [Full Text] [Related]

  • 12. Vessel-sparing Radiotherapy for Localized Prostate Cancer to Preserve Erectile Function: A Single-arm Phase 2 Trial.
    Spratt DE, Lee JY, Dess RT, Narayana V, Evans C, Liss A, Winfield R, Schipper MJ, Lawrence TS, McLaughlin PW.
    Eur Urol; 2017 Oct 15; 72(4):617-624. PubMed ID: 28233591
    [Abstract] [Full Text] [Related]

  • 13. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
    van Lin EN, Fütterer JJ, Heijmink SW, van der Vight LP, Hoffmann AL, van Kollenburg P, Huisman HJ, Scheenen TW, Witjes JA, Leer JW, Barentsz JO, Visser AG.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):291-303. PubMed ID: 16618584
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interobserver comparison of CT and MRI-based prostate apex definition. Clinical relevance for conformal radiotherapy treatment planning.
    Wachter S, Wachter-Gerstner N, Bock T, Goldner G, Kovacs G, Fransson A, Pötter R.
    Strahlenther Onkol; 2002 May 01; 178(5):263-8. PubMed ID: 12082686
    [Abstract] [Full Text] [Related]

  • 17. Using CT imaging to delineate the prostatic apex for radiation treatment planning.
    Li XM, Gao XS, Guo XM, Li YG, Wang XY.
    Chin J Cancer; 2010 Nov 01; 29(11):914-22. PubMed ID: 20979690
    [Abstract] [Full Text] [Related]

  • 18. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy.
    Taussky D, Haider M, McLean M, Yeung I, Williams T, Pearson S, Lockwood G, Crook J.
    Brachytherapy; 2004 Nov 01; 3(3):125-9. PubMed ID: 15533803
    [Abstract] [Full Text] [Related]

  • 19. Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with 125I low dose rate brachytherapy for localized prostate cancer.
    Chasseray M, Dissaux G, Bourbonne V, Boussion N, Goasduff G, Malloreau J, Malhaire JP, Fournier G, Tissot V, Pradier O, Valeri A, Schick U.
    Acta Oncol; 2019 Jul 01; 58(7):1029-1035. PubMed ID: 30761939
    [Abstract] [Full Text] [Related]

  • 20. Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing.
    Benhmida S, Beneux A, Udrescu C, Rouviere O, Horn S, Enachescu C, Lapierre A, Chapet O.
    Br J Radiol; 2021 Nov 01; 94(1127):20210142. PubMed ID: 34283647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.